Their new products look very promising indeed. However, the convertible debt out weights all recent positive news. If they can reduce it by 50% or more, then the stock will appreciate in value. Personally, I'm not ready to invest here, but a lot can change by the end of this quarter. From the filings, they must pay or renegotiate ~ 15M in convertible notes by October 9th. I expect they will tap in to the remaining portion of the 1B authorized shares to do so.
News 
Market Data 
Discover 
